National Health Investors (NHI) Cash from Financing Activities (2009 - 2026)

National Health Investors has reported Cash from Financing Activities for 18 years, with the latest figure at $55.8 million in Q1 2026.

• For the quarter ending Q1 2026, Cash from Financing Activities fell 60.1% year-over-year to $55.8 million; the trailing twelve-month figure through Mar 2026 stood at -$58.3 million (down 135.95% YoY), and the FY2025 full-year result was $25.7 million, up 289.48% from the prior year.
• Cash from Financing Activities for Q1 2026 stood at $55.8 million, down from $57.3 million in the prior quarter.
• The five-year high for Cash from Financing Activities was $139.8 million in Q1 2025, with the low at -$244.9 million in Q2 2022.
• Historically, Cash from Financing Activities has averaged -$29.6 million across 5 years, with a median of -$36.2 million in 2022.
• Annual changes were most pronounced in 2023 — Cash from Financing Activities tumbled 571.7% — and 2025, when it surged 489.08%.
• National Health Investors' Cash from Financing Activities stood at -$7.4 million in 2022, then plunged by 571.7% to -$49.4 million in 2023, then soared by 327.37% to $112.4 million in 2024, then plunged by 49.01% to $57.3 million in 2025, then declined by 2.66% to $55.8 million in 2026.
• The last three Cash from Financing Activities figures came in at $55.8 million (Q1 2026), $57.3 million (Q4 2025), and -$41.9 million (Q3 2025), per Business Quant data.